Diego Montagner

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Venues

Molecules (Basel, Switzerland)

Dalton transactions (Cambridge, England : 2003)

International journal of molecular sciences

ChemMedChem

Maynooth University

University of Padua (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Maynooth University Jan 01 2016

Ireland

Lecturer :: Chemistry

National University of Ireland Galway Jan 01 2015 - Dec 31 2015

Ireland

Lecturer :: Chemistry

National University of Ireland Galway Jul 01 2013 - Dec 31 2014

Ireland

Marie Curie Post Doc :: Chemistry

National University of Singapore Jan 01 2012 - Jun 30 2013

Singapore

Postdoc :: Chemistry

Education History

University of Padua Jan 01 2005 - Mar 17 2008

Italy

PHD :: Chemistry

Publications

Giulia Ferrari, Ines Lopez-Martinez, Thomas Wanek, Claudia Kuntner, Diego Montagner
Recent Advances on Pt-Based Compounds for Theranostic Applications. Molecules (Basel, Switzerland) 29 (15) (2024)
Giulia Ferrari, Ines Lopez-Martinez, Thomas Wanek, Claudia Kuntner, Diego Montagner
Recent Advances on Pt-Based Compounds for Theranostic Applications. Molecules (Basel, Switzerland) 29 (15) (2024)
Eoin Moynihan, Silvia Panseri, Giada Bassi, Arianna Rossi, Elisabetta Campodoni, Eithne Dempsey, Monica Montesi, Trinidad Velasco-Torrijos, Diego Montagner
Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma. International journal of molecular sciences 24 (7) (2023)
Stephen Barrett, Michele De Franco, Chiara Donati, Cristina Marzano, Valentina Gandin, Diego Montagner
Novel Biotinylated Cu(II)-Phenanthroline Complexes: 2D and 3D Cytotoxic Activity and Mechanistic Insight. Molecules (Basel, Switzerland) 28 (10) (2023)
Darren Fergal Beirne, Barbara Farkaš, Chiara Donati, Valentina Gandin, Isabel Rozas, Trinidad Velasco-Torrijos, Diego Montagner
Novel design of dual-action Pt(IV) anticancer pro-drugs based on cisplatin and derivatives of the tyrosine kinase inhibitors imatinib and nilotinib. Dalton transactions (Cambridge, England : 2003) (2023)
Elena Giusto, Ludmila Žárská, Darren Fergal Beirne, Arianna Rossi, Giada Bassi, Andrea Ruffini, Monica Montesi, Diego Montagner, Václav Ranc, Silvia Panseri
Graphene Oxide Nanoplatforms to Enhance Cisplatin-Based Drug Delivery in Anticancer Therapy. Nanomaterials (Basel, Switzerland) 12 (14) (2022)
Stephen Barrett, Michele De Franco, Andrew Kellett, Eithne Dempsey, Cristina Marzano, Andrea Erxleben, Valentina Gandin, Diego Montagner
Anticancer activity, DNA binding and cell mechanistic studies of estrogen-functionalised Cu(II) complexes. Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 25 (1) (2019)
Andrea Pettenuzzo, Diego Montagner, Patrick McArdle, Luca Ronconi
An innovative and efficient route to the synthesis of metal-based glycoconjugates: proof-of-concept and potential applications. Dalton transactions (Cambridge, England : 2003) 47 (31) (2018)
Keefe Guang Zhi Lee, Maria V Babak, Andrea Weiss, Paul J Dyson, Patrycja Nowak-Sliwinska, Diego Montagner, Wee Han Ang
Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug. ChemMedChem 13 (12) (2018)
Diego Montagner, Dina Tolan, Emma Andriollo, Valentina Gandin, Cristina Marzano
A Pt(IV) Prodrug Combining Chlorambucil and Cisplatin: a Dual-Acting Weapon for Targeting DNA in Cancer Cells. International journal of molecular sciences 19 (12) (2018)

Diego Montagner.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Diego Montagner